Clinical Trials

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer


Study ID
SWOG S1207

NCT Number
NCT01674140 (Click on the NCT number for more information about the trial)

Research Study Number
00003816

Principle Investigator
Dr. Stanley Waintraub

Phase
III

Sponsor
SWOG


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now